254
Views
5
CrossRef citations to date
0
Altmetric
ASSISTED REPRODUCTION

Outcomes of in vitro fertilization–embryo transfer in women with diminished ovarian reserve after growth hormone pretreatment

, , , &
Pages 955-958 | Received 04 Oct 2019, Accepted 26 Feb 2020, Published online: 14 Mar 2020

References

  • Nardo LG, Tarek ET, Jane S, et al. British Fertility Society Policy and Practice Committee: adjuvants in IVF: evidence for good clinical practice. Hum Fertil (Camb). 2015;18(1):2–15.
  • Lessey BA, Castelbaum AJ, Sawin SW, et al. Integrins as markers of uterine receptivity in women with primary unexplained infertility. Fertil Steril. 1995;63(3):535–542.
  • Weall BM, Al-Samerria S, Conceicao J, et al. A direct action for GH in improvement of oocyte quality in poor-responder patients. Reproduction. 2015;149(2):147–154.
  • Regan SLP, Knight PG, Yovich JL, et al. Growth hormone during in vitro fertilization in older women modulates the density of receptors in granulosa cells, with improved pregnancy outcomes. Fertil Steril. 2018;110(7):1298–1310.
  • Kolibianakis EM, Venetis CA, Diedrich K, et al. Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2009;15(6):613–622.
  • Ob’edkova K, Kogan I, Krikheli I, et al. Growth hormone co-treatment in IVF/ICSI cycles in poor responders. Gynecol Endocrinol. 2017;33(Suppl. 1):15–17.
  • Choe SA, Kim MJ, Lee HJ, et al. Increased proportion of mature oocytes with sustained-release growth hormone treatment in poor responders: a prospective randomized controlled study. Arch Gynecol Obstet. 2018;297(3):791–796.
  • Norman RJ, Alvino H, Hull LM, et al. Human growth hormone for poor responders: a randomized placebo-controlled trial provides no evidence for improved live birth rate. Reprod Biomed Online. 2019;38(6):908–915.
  • Li XL, Wang L, Lv F, et al. The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: a systematic review and meta-analysis. Medicine (Baltimore). 2017;96(12):e6443.
  • Du XF, Yang XH, Li J, et al. Growth hormone co-treatment within a GnRH agonist long protocol improves implantation and pregnancy rates in patients undergoing IVF-ET. Arch Gynecol Obstet. 2016;294(4):877–883.
  • Bassiouny YA, Dakhly DMR, Bayoumi YA, et al. Does the addition of growth hormone to the in vitro fertilization/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial. Fertil Steril. 2016;105(3):697–702.
  • Dakhly DMR, Bassiouny YA, Bayoumi YA, et al. The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: randomized control trial. Eur J Obstet Gynecol Reprod Biol. 2018;228:161–165.
  • Chu K, Pang W, Sun N, et al. Outcomes of poor responders following growth hormone co-treatment with IVF/ICSI mild stimulation protocol: a retrospective cohort study. Arch Gynecol Obstet. 2018;297(5):1317–1321.
  • Keane KN, Yovich JL, Hamidi A, et al. Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis. BMJ Open. 2017;7(10):e018107.
  • Dunne C, Seethram K, Roberts J. Growth hormone supplementation in the luteal phase before microdose GnRH agonist flare protocol for in vitro fertilization. J Obstet Gynaecol Can. 2015;37(9):810–815.
  • Cai MH, Liang XY, Wu YQ, et al. Six-week pretreatment with growth hormone improves clinical outcomes of poor ovarian responders undergoing in vitro fertilization treatment: a self-controlled clinical study. J Obstet Gynaecol Res. 2018;45(2):376–381.
  • Yun BH, Kim G, Park SH, et al. In vitro fertilization outcome in women with diminished ovarian reserve. Obstet Gynecol Sci. 2017;60(1):46–52.
  • Ferraretti AP, La Marca A, Fauser BC, et al. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616–1624.
  • Klinkert ER, Broekmans FJ, Looman CW, et al. A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles. Fertil Steril. 2004;81(5):1247–1253.
  • Chen Y, Nisenblat V, Yang P, et al. Reproductive outcomes in women with unicornuate uterus undergoing in vitro fertilization: a nested case-control retrospective study. Reprod Biol Endocrinol. 2018;16(1):64.
  • Liu N, Ma Y, Li R, et al. Comparison of follicular fluid amphiregulin and EGF concentrations in patients undergoing IVF with different stimulation protocols. Endocrine. 2012;42(3):708–716.
  • Xu YYN, Lu C, Li R, et al. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial. Reprod Biol Endocrinol. 2018;16(1):29.
  • Erickson GF, Garzo VG, Magoffin DA. Insulin-like growth factor-I regulates aromatase activity in human granulosa and granulosa luteal cells. J Clin Endocrinol Metab. 1989;69(4):716–724.
  • Yoshimura Y, Ando M, Nagamatsu S, et al. Effects of insulin-like growth factor-I on follicle growth, oocyte maturation, and ovarian steroidogenesis and plasminogen activator activity in the rabbit. Biol Reprod. 1996;55(1):152–160.
  • Mendoza C, Cremades N, Ruiz-Requena E, et al. Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations. Hum Reprod. 1999;14(3):628–635.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.